Barrios, Carlos H. http://orcid.org/0000-0001-6021-667X
Saji, Shigehira
Harbeck, Nadia http://orcid.org/0000-0002-9744-7372
Zhang, Hong
Jung, Kyung H.
Patel, Sheetal
Patel, Shilpen
Duc, Anh Nguyen
Liste-Hermoso, Mario
Chui, Stephen Y.
Mittendorf, Elizabeth A.
Funding for this research was provided by:
Roche
Article History
Received: 15 November 2021
Accepted: 11 July 2022
First Online: 19 September 2022
Competing interests
: All authors received support from Genentech, Inc., during the conduct of the study. Editorial support provided by an independent medical writer, under the guidance of the authors, was funded by the sponsor. The authors declare no competing non-financial interests except as noted below. C.H.B. reports institutional grants and research support from Pfizer, Novartis, Amgen, AstraZeneca, Boehringer Ingelheim, GSK, Roche/Genentech, Lilly, Sanofi, Taiho Pharmaceutical, Mylan, Merrimack, Merck, AbbVie, Astellas Pharma, BioMarin, Bristol Myers Squibb, Daiichi Sankyo, Abraxis Biosciences, AB Science, Asana Biosciences, Medivation, Exelixis, ImClone Systems, LEO Pharma, and Millennium; and fees for serving on advisory boards and consulting from Boehringer Ingelheim, GSK, Novartis, Pfizer, Roche/Genentech, Eisai, Bayer, MSD, and AstraZeneca. S.S. has received speaking and consulting fees from Chugai, Kyowa Kirin, and Novartis; and speaking fees and/or grants from Lilly, AstraZeneca, Pfizer, MSD, Eisai, Takeda, and Taiho. N.H. has received personal fees from AstraZeneca, Bristol Myers Squibb, MSD, and Roche. H.Z. has received consulting fees from Roche/Genentech. K.H.J. has received personal fees from Roche, Novartis, AstraZeneca, Takeda, and Celgene. She.P. and Shi.P. are employees and stockholders of Roche/Genentech. A.N.D is an employee of Roche and has a patent pending relevant to this work. M.L.-H. is an employee and stockholder of Roche. S.Y.C. is an employee of and stockholder in Roche/Genentech and has a patent pending relevant to this work. E.A.M. reports research support from GSK; honoraria from Physicians’ Education Resource; compensation for serving on advisory boards from AstraZeneca, Exact Sciences, Merck, Peregrine Pharmaceuticals, Roche/Genentech, SELLAS Life Sciences, and TapImmune; institutional support from AstraZeneca, EMD Serono, Galena Biopharma, and Roche/Genentech; and serving as an uncompensated steering committee member for Bristol Myers Squibb, Lilly, and Roche/Genentech.